Atossa Therapeutics (ATOS) Free Cash Flow (2011 - 2026)
Atossa Therapeutics (ATOS) free cash flow from Sep 30, 2011 to Mar 31, 2026. The TTM Atossa Therapeutics (ATOS) free cash flow is -$33M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Atossa Therapeutics (ATOS) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +49.71% |
| 3 Years TTM | +13.37% |
| 5 Years TTM | +21.22% |
| 10 Years TTM | +9.13% |
| All Time TTM | +13.71% |
Annual Free Cash Flow change of Atossa Therapeutics (ATOS)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$9.58M | -67.83% |
| 2025 | -$30M | +41.47% |
| 2024 | -$21M | +0.48% |
| 2023 | -$21M | +0.77% |
| 2022 | -$21M | +26.15% |
| 2021 | -$16M | +42.31% |
| 2020 | -$12M | +26.70% |
| 2019 | -$9.14M | +0.77% |
| 2018 | -$9.07M | +37.63% |
| 2017 | -$6.59M | +22.72% |
| 2016 | -$5.37M | -61.51% |
| 2015 | -$14M | -0.36% |
| 2013 | -$14M | +258.97% |
| 2012 | -$3.90M | +11.75% |
| 2011 | -$3.49M | N/A |
Comparison Atossa Therapeutics (ATOS) five years free cash flow CAGR with competitors
Atossa Therapeutics (ATOS) five years free cash flow CAGR is 21.22%.